This report contains market size and forecasts of Potassium Sodium Pehydroandroandrographolide Succinate for Injection in global, including the following market information:
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Potassium Sodium Pehydroandroandrographolide Succinate for Injection companies in 2021 (%)
The global Potassium Sodium Pehydroandroandrographolide Succinate for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intramuscular Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Potassium Sodium Pehydroandroandrographolide Succinate for Injection include Zhuhai Tongyuan Pharmaceutical, Chengdu Tiantai Mount Pharmaceutical, Sinopharm Guorui Pharmaceutical, ZBT Pharmaceutical, Nirvana Pharmaceutical, Youcare Pharmaceutical Group Co.,Ltd., Pudepharma and Chongqing Lummy Pharmaceutical Co.,Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Potassium Sodium Pehydroandroandrographolide Succinate for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market Segment Percentages, by Type, 2021 (%)
Intramuscular Injection
Intravenous Drip
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market Segment Percentages, by Application, 2021 (%)
Viral Pneumonia
Viral Upper Respiratory Tract Infection
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Potassium Sodium Pehydroandroandrographolide Succinate for Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Potassium Sodium Pehydroandroandrographolide Succinate for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Potassium Sodium Pehydroandroandrographolide Succinate for Injection revenues share in global market, 2021 (%)
Key companies Potassium Sodium Pehydroandroandrographolide Succinate for Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Potassium Sodium Pehydroandroandrographolide Succinate for Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zhuhai Tongyuan Pharmaceutical
Chengdu Tiantai Mount Pharmaceutical
Sinopharm Guorui Pharmaceutical
ZBT Pharmaceutical
Nirvana Pharmaceutical
Youcare Pharmaceutical Group Co.,Ltd.
Pudepharma
Chongqing Lummy Pharmaceutical Co.,Ltd